ArticleAntibody therapeutics2021
An optimal antitumor response by a novel CEA/CD3 bispecific antibody for colorectal cancers.
Ninghai Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled itcites it